Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension

Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) can be idiopathic or secondary to autoimmune diseases, and it represents one of the most threatening complications of systemic sclerosis (SSc). Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine with proinflammatory functions that appears to...

Full description

Bibliographic Details
Main Authors: K. Stefanantoni, I. Sciarra, M. Vasile, R. Badagliacca, R. Poscia, M. Pendolino, C. Alessandri, C.D. Vizza, G. Valesini, V. Riccieri
Format: Article
Language:English
Published: PAGEPress Publications 2015-03-01
Series:Reumatismo
Subjects:
Pulmonary arterial hypertension, Systemic sclerosis, Macrophage migration inhibitory factor, Stem cell growth factor β, Biomarkers.
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/774

Internet

http://www.reumatismo.org/index.php/reuma/article/view/774

Similar Items